Skip to main content

Diagnostic options ยท UAE

Biochemistry tests in Dubai & UAE

Compare available Biochemistry tests, their listed prices and the information provided for each option. Test selection and preparation should be discussed with your clinician.

Tests in this category

1,113

Listed price range

450.00โ€“30,000.00 AED

Clinical preparation

Confirm test-specific instructions with your clinician or laboratory.

Compare available tests

Biochemistry test prices

Showing 301โ€“315 of 1,113 matching tests.

Biochemistry diagnostic tests, details, and listed prices
Test and description Specimen Typical duration Price Options
TEST-988
Dexamethasone Therapeutic Drug Monitoring Test

This test measures the concentration of dexamethasone in the blood serum to guide therapeutic dosing.

Serum 2โ€“3 weeks 1,800.00 AED
View
View test specifications and preparation
What it measures
["Serum Dexamethasone Concentration"]
Parameters
[{"name": "Serum Dexamethasone", "reference_range": null}]
Preparation
["Fasting serum sample required", "Sample collection between 8โ€“10 AM", "Use red-top tube (no SST gel)", "Keep specimen refrigerated or frozen immediately"]
Indications
["Patients on long-term or high-dose corticosteroid therapy", "Management of inflammatory conditions", "Management of autoimmune conditions", "Management of adrenal insufficiency", "Anti-aging protocols involving corticosteroids"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 19633-6 ICD-10: Z51.81
Clinical summary
This test measures the concentration of dexamethasone in the blood serum to guide therapeutic dosing.
TEST-992
DHEA Stimulation Test (ACTH Stimulation)

This test evaluates adrenal gland reserve by measuring DHEA response to synthetic ACTH stimulation.

Serum (Peripheral Blood) Same Day (sample drawn Tue/Fri by 9 AM) 1,000.00 AED
View
View test specifications and preparation
What it measures
["DHEA levels at baseline", "DHEA levels 90 minutes post-ACTH stimulation", "Adrenal gland reserve"]
Parameters
[{"name": "DHEA Baseline", "reference_range": null}, {"name": "DHEA Post-Stimulation (90 min)", "reference_range": null}, {"name": "Delta DHEA", "reference_range": null}]
Preparation
["Overnight fasting of 10โ€“12 hours is mandatory; only water is permitted.", "Do not discontinue prescribed corticosteroids, estrogen therapy, or DHEA supplements without consulting your doctor.", "Apply no creams or lotions to your arms on the day of collection."]
Indications
["Diagnosing subtle or partial adrenal insufficiency", "Diagnosing adult-onset congenital adrenal hyperplasia", "Guiding anti-aging and hormone optimization protocols"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 28620-4 ICD-10: E27.1, E27.2, E24.0
Clinical summary
This test evaluates adrenal gland reserve by measuring DHEA response to synthetic ACTH stimulation.
TEST-3721
DHH Gene Mutation Analysis for 46,XY Gonadal Dysgenesis & Minifascicular Neuropathy Test

This diagnostic test evaluates the DHH gene for pathogenic variants associated with 46,XY gonadal dysgenesis and minifascicular neuropathy.

Peripheral Whole Blood, Serum, or Plasma 3-4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the DHH gene", "Coding exons and intron-exon boundaries"]
Parameters
[]
Preparation
["No specific fasting required", "Inform lab of any anticoagulant therapy"]
Indications
["Suspected 46,XY gonadal dysgenesis", "Suspected minifascicular neuropathy", "Family history of DHH-related disorders"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 50396-0 ICD-10: Q99.1, G60.0
Clinical summary
This diagnostic test evaluates the DHH gene for pathogenic variants associated with 46,XY gonadal dysgenesis and minifascicular neuropathy.
TEST-6010
DHTKD1 Gene Analysis (2-Aminoadipic 2-Oxoadipic Aciduria) Test

This test identifies pathogenic variants in the DHTKD1 gene associated with 2-aminoadipic 2-oxoadipic aciduria.

Whole Blood (EDTA), Extracted DNA, or Dried Blood Spot (FTA Card) 3โ€“4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the DHTKD1 gene"]
Parameters
[]
Preparation
["Do not discontinue prescribed medication without physician instruction", "Pre-test genetic counseling session required"]
Indications
["Suspected 2-aminoadipic 2-oxoadipic aciduria", "Family history of the disorder", "Confirmation following suggestive biochemical screening"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 81261-8 ICD-10: E72.52
Clinical summary
This test identifies pathogenic variants in the DHTKD1 gene associated with 2-aminoadipic 2-oxoadipic aciduria.
TEST-986
Diabetes Panel 2 Test

This diagnostic test evaluates glycemic control and early renal function related to diabetes.

Fasting venous blood & first-morning urine Same Day (reported by 9 PM) 550.00 AED
View
View test specifications and preparation
What it measures
["Fasting Plasma Glucose", "Two-hour Postprandial Glucose", "Glycated Hemoglobin (HbA1c)", "Urine Glucose", "Urine Ketones", "Urine Microalbumin"]
Parameters
[{"name": "Fasting Glucose", "reference_range": null}, {"name": "Postprandial Glucose", "reference_range": null}, {"name": "HbA1c", "reference_range": null}, {"name": "Urine Glucose", "reference_range": null}, {"name": "Urine Ketones", "reference_range": null}, {"name": "Urine Microalbumin", "reference_range": null}]
Preparation
["Strict 12-hour overnight fasting required.", "Water is permitted in small sips only.", "Do not discontinue prescribed antidiabetic medication unless directed by your physician."]
Indications
["Screening for diabetes", "Diagnosis of diabetes", "Monitoring glycemic control in known diabetics", "Assessment of early renal involvement"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 51992-3 ICD-10: R73.09
Clinical summary
This diagnostic test evaluates glycemic control and early renal function related to diabetes.
TEST-1003
Diazepam Blood Level Test (TDM)

This diagnostic test evaluates the concentration of diazepam and its metabolites in the patient's serum or plasma.

Peripheral Serum or Plasma 2โ€“3 weeks 2,000.00 AED
View
View test specifications and preparation
What it measures
["Serum Diazepam", "Diazepam Metabolites"]
Parameters
[{"name": "Diazepam", "reference_range": null}, {"name": "Nordiazepam (Desmethyldiazepam)", "reference_range": null}, {"name": "Temazepam", "reference_range": null}, {"name": "Oxazepam", "reference_range": null}]
Preparation
["Schedule blood draw just before next scheduled dose (trough level)", "Continue all medications as prescribed", "Bring completed consent form"]
Indications
["Long-term benzodiazepine therapy", "Suspected toxicity or non-adherence", "Dosage adjustments", "Monitoring drug interactions"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 3948-7 ICD-10: Z51.81
Clinical summary
This diagnostic test evaluates the concentration of diazepam and its metabolites in the patient's serum or plasma.
TEST-993
Digitoxin Test (Therapeutic Drug Monitoring)

This test measures the concentration of digitoxin in the blood serum to monitor therapeutic levels and prevent toxicity.

Serum 2-3 weeks 2,600.00 AED
View
View test specifications and preparation
What it measures
["Serum digitoxin concentration"]
Parameters
[{"name": "Digitoxin", "reference_range": null}]
Preparation
["Fast for at least 4 hours", "Schedule blood draw just before next scheduled dose", "Bring mandatory consent form"]
Indications
["Monitoring digitoxin therapy", "Assessing risk of digitalis toxicity", "Patients with heart failure or atrial fibrillation on digitoxin"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 3352-0 ICD-10: Z51.81
Clinical summary
This test measures the concentration of digitoxin in the blood serum to monitor therapeutic levels and prevent toxicity.
TEST-1015
Disopyramide Drug Level Monitoring Test

This diagnostic test evaluates the serum concentration of disopyramide to guide therapeutic dosing.

Serum 2โ€“3 weeks after sample receipt by the 7th of the month 1,800.00 AED
View
View test specifications and preparation
What it measures
["Serum Disopyramide Concentration"]
Parameters
[{"name": "Disopyramide", "reference_range": null}]
Preparation
["No fasting required", "Inform phlebotomist about all medications", "Sign Test Send Out Consent Form (Form 35)"]
Indications
["Monitoring therapy for cardiac arrhythmias", "Assessing potential drug toxicity", "Optimizing disopyramide dosage"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 3395-7 ICD-10: Z51.81
Clinical summary
This diagnostic test evaluates the serum concentration of disopyramide to guide therapeutic dosing.
TEST-5907
DLAT Gene (Pyruvate Dehydrogenase E2 Deficiency) Genetic Test

This genetic test identifies pathogenic variants in the DLAT gene associated with Pyruvate Dehydrogenase E2 Deficiency.

Peripheral Whole Blood / FTA Card 3โ€“4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["DLAT gene sequence variants", "Pathogenic mutations in coding exons and flanking intronic regions"]
Parameters
[]
Preparation
["No fasting required", "No medication change required", "Mandatory pre-genetic counselling session"]
Indications
["Suspected Pyruvate Dehydrogenase E2 Deficiency", "Family history of metabolic disorders", "Unexplained neurological symptoms"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 94248-9 ICD-10: E74.4
Clinical summary
This genetic test identifies pathogenic variants in the DLAT gene associated with Pyruvate Dehydrogenase E2 Deficiency.
TEST-6037
DLD Gene Maple Syrup Urine Disease Type 3 Genetic Test

This test evaluates the DLD gene for pathogenic variants associated with Maple Syrup Urine Disease Type 3.

Peripheral Whole Blood (Venous) 3โ€“4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the DLD gene", "Branched-chain amino acid metabolism disorder"]
Parameters
[]
Preparation
[]
Indications
["Suspected Maple Syrup Urine Disease Type 3", "Carrier screening for family planning", "Diagnosis in symptomatic individuals"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 86900-3 ICD-10: E71.0
Clinical summary
This test evaluates the DLD gene for pathogenic variants associated with Maple Syrup Urine Disease Type 3.
TEST-4508
DLX3 Gene Trichodentoosseous Syndrome Genetic Test

This test evaluates the DLX3 gene for mutations associated with Trichodentoosseous Syndrome (TDO). It identifies pathogenic variants causing hair, dental, and bone abnormalities.

Peripheral Whole Blood or FTA Card Spot 3โ€“4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["DLX3 gene sequence", "Single nucleotide variants", "Small insertions/deletions"]
Parameters
[]
Preparation
["No fasting required", "No medication cessation required"]
Indications
["Suspected Trichodentoosseous Syndrome", "Family history of TDO", "Carrier screening for at-risk relatives", "Reproductive planning"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 21637-8 ICD-10: Q87.8
Clinical summary
This test evaluates the DLX3 gene for mutations associated with Trichodentoosseous Syndrome (TDO). It identifies pathogenic variants causing hair, dental, and bone abnormalities.
TEST-2275
DLX5 Gene Split-Hand/Foot Malformation Type 1 with Sensorineural Hearing Loss Genetic Test

This genetic test evaluates the DLX5 gene for pathogenic mutations linked to Split-Hand/Foot Malformation Type 1 and sensorineural hearing loss.

Whole Blood (EDTA), Extracted DNA, or FTA Card 3โ€“4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic mutations in the DLX5 gene", "Coding regions and splice sites of DLX5"]
Parameters
[]
Preparation
["Pre-test genetic counseling session is mandatory.", "Informed consent must be documented."]
Indications
["Diagnosis of Split-Hand/Foot Malformation Type 1 (SHFM1)", "Diagnosis of sensorineural hearing loss associated with DLX5 mutations", "Genetic counseling for families with a history of SHFM1 or related hearing loss"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 93711-0 ICD-10: Q71.6, Q72.5, Q73.8, H90.3
Clinical summary
This genetic test evaluates the DLX5 gene for pathogenic mutations linked to Split-Hand/Foot Malformation Type 1 and sensorineural hearing loss.
TEST-1636
DMD/BMD Mutation Screening (26 Exons) Test

This test screens for common deletions and duplications within the 26 exons of the DMD gene, associated with Duchenne and Becker muscular dystrophies.

Amniotic fluid or chorionic villus sampling 4โ€“5 business days 1,400.00 AED
View
View test specifications and preparation
What it measures
["Deletions in DMD gene exons", "Duplications in DMD gene exons"]
Parameters
[]
Preparation
[]
Indications
["Family history of DMD/BMD", "Known maternal carrier status", "Clinical suspicion during pregnancy"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 87762-1 ICD-10: G71.0
Clinical summary
This test screens for common deletions and duplications within the 26 exons of the DMD gene, associated with Duchenne and Becker muscular dystrophies.
TEST-6346
DMGDH Gene (Dimethylglycine Dehydrogenase Deficiency) Genetic Test

This genetic test identifies pathogenic variants in the DMGDH gene associated with dimethylglycine dehydrogenase deficiency.

Whole blood (EDTA), DNA FTA Card, or Extracted DNA (peripheral blood) 3 โ€“ 4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["Pathogenic variants in the DMGDH gene"]
Parameters
[]
Preparation
["Fasting is not required", "Provide whole blood, DNA FTA card, or extracted DNA"]
Indications
["Suspected dimethylglycine dehydrogenase deficiency", "Family history of the disorder", "Genetic counselling for at-risk relatives"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 94558-4 ICD-10: E72.8, E72.9
Clinical summary
This genetic test identifies pathogenic variants in the DMGDH gene associated with dimethylglycine dehydrogenase deficiency.
TEST-5028
DMP1 Gene Autosomal Recessive Hypophosphatemic Rickets Type 1 (ARHR1) Genetic Test

This test evaluates the DMP1 gene for mutations associated with Autosomal Recessive Hypophosphatemic Rickets Type 1 (ARHR1).

Whole Blood (EDTA) or Extracted DNA or FTA Card 3โ€“4 Weeks 2,800.00 AED
View
View test specifications and preparation
What it measures
["DMP1 gene sequence", "Pathogenic variants in DMP1"]
Parameters
[]
Preparation
["Pre-test genetic counselling session recommended", "Inform lab about recent blood transfusions"]
Indications
["Suspected Autosomal Recessive Hypophosphatemic Rickets Type 1 (ARHR1)", "Family history of ARHR1", "Evaluation of hypophosphatemia with skeletal abnormalities"]
Measurement technique
Confirm with laboratory
Codes
LOINC: 79692-0 ICD-10: E83.31, Z13.79, Z82.79
Clinical summary
This test evaluates the DMP1 gene for mutations associated with Autosomal Recessive Hypophosphatemic Rickets Type 1 (ARHR1).

Category overview

Biochemistry: overview

Seeking clarity about your body's essential functions is vital for long-term well-being. At DNA Labs UAE, our Biochemistry services utilize advanced automated analyzers to evaluate enzymes, proteins, and metabolites in your blood. Whether you need routine metabolic panels or specialized biochemical testing in the UAE, these tests provide critical data to guide your physician's medical plan. As a leading diagnostic lab in Dubai and the UAE, we guarantee strict confidentiality and rapid, accurate turnaround times. Take charge of your health today. Explore our biochemistry diagnostics below, schedule a convenient home sample collection, or contact our specialists to book your test.

Before booking

Use the test details as a conversation starter

The right diagnostic option depends on your reason for testing and individual circumstances. Check the listed specimen and timing, then confirm any preparation requirements with the ordering clinician or laboratory before collection.

Explore this area